Search results
12-year-old beats rare brain cancer but after 3 years remission is now battling a new form of brain ...
WZZM 13 Grand Rapids· 1 day agoNearly six years ago, now 12-year-old Emerson Hoogendoorn was diagnosed with diffuse midline glioma,...
Gaston 6-year-old to have the summer of her life while fighting cancer
The Gaston Gazette via Yahoo News· 1 day agoA Gaston family is seeking solace in the community as six-year-old Harmony Nicholson’s months-long...
New research platform assesses brain cancer mutations during surgery
Medical Xpress· 7 days agoBrain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published ...
Mother backs Epsom Derby auction to honour daughter
BBC via AOL· 7 days agoFunds raised by the event will be used by the charity for research at its centres across the UK, with the aim of finding a cure for brain cancer. Emily,...
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 3 days agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...
Walk six laps for Emerson the Brave, a 12-year-old battling cancer in Holland
The Holland Sentinel· 3 days ago— A walkathon next week will raise funds for a local child battling brain cancer. West Ottawa Public...
Community supports 12-year-old cancer patient who ‘beat the unbeatable’
WOOD via Yahoo News· 3 days agoEmerson Hoogendoorn's loved ones say she can be described in many words: kind, strong, giving. But...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoSapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
Researchers report encouraging Phase 1 data for glioblastoma treatment
Medical Xpress· 15 hours agoMina Lobbous, M.D., assistant professor of neurology at Cleveland Clinic (after completing his Neuro-Oncology fellowship at UAB) was the poster presenter. This survival data along with radiographic ...